SAN DIEGO May 2 2017 PRNewswire Arena Pharmaceuticals Inc. NASDAQ ARNA a biopharmaceutical company focused on developing novel small molecule drugs across multiple therapeutic areas today announced that the Company will release its first quarter 2017 fina...
↧